However, TLR4 knockout mice completely lack an IL-6 response, and IL-6 may be a more promising therapeutic target for preventing or alleviating chemotherapy-induced gastrointestinal mucositis (Khan et al., 2018). This evidence concerns the gene IL6 and gastrointestinal mucositis.